Skip to main content
Caplight Logo









Ocutrx Technologies, Inc.

Ocutrx Technologies, Inc.

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.ocutrxtech.com/

Last Round

Series C

Nov 15, 2023

Total Funding Raised

$25M

Company Overview

Ocutrx Technologies, Inc. is a medical technology company that develops augmented reality (AR) and extended reality (XR) headsets and visualization platforms for healthcare, including the OcuLenz™ for patients with macular degeneration and the OR-Bot™ 3D Surgical Visualization Theatre.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, Medical Imaging, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

AR headsetsurgical visualizationlow vision aidmedical deviceMedTechAdvanced Macular DegenerationAMDsurgical ARXR headsetdigital loupessurgical headsetspatial computingoperating room technologycobotic surgeryassistive technologymedical imagingvertical integrationdefense tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ocutrx Technologies, Inc. Comparables

Compare Ocutrx Technologies, Inc. with similar companies based on industry and business-model similarity.

Ocutrx Technologies, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NuEyes Technologies Inc.
89%
Eyedaptic Inc.
79%
Augmedics
78%

Ocutrx Technologies, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 15, 2023
DebtApr 12, 2023

Key People

Founding team and executive leadership

Jordan Boss

Chief Executive Officer

Executive Team

Michael Freeman

Chief Executive Officer

Executive Team

Kevin Griffin

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors increased 835% MoM.

  • Jan 16, 2025

    Grew 16% QoQ, from 19 to 22 employees.

Ocutrx Technologies, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ocutrx Technologies, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ocutrx Technologies, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California
Employee Range17
Year Founded2015
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?